<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://mesowatch.org/news/2026/07/rso-021-prx3-mesothelioma-phase1/</loc>
    <news:news>
      <news:publication>
        <news:name>MesoWatch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-27T00:00:00.000Z</news:publication_date>
      <news:title>Mesothelioma Drug RSO-021 Controlled Disease in 6 of 9 People</news:title>
      <news:keywords>research, study, medical research, clinical-trial, rso-021, thiostrepton, prx3, bap1, mesothelioma</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://mesowatch.org/og/news/2026/07/rso-021-prx3-mesothelioma-phase1.png</image:loc>
    </image:image>
  </url>
</urlset>